CGWS(SZ:002939) Nan Fang Du Shi Bao·2025-09-19 10:32Core Viewpoint - Changcheng Securities has filed a lawsuit against Shenzhen Sanjiu Weitai Co., Ltd. for a "shareholder qualification confirmation dispute," despite the latter being a "revoked" company and no longer in operation [2][3][5]. Group 1: Lawsuit Details - The lawsuit requests three main points: 1) confirmation of Changcheng Securities as a shareholder holding 900,000 shares; 2) issuance of share certificates and registration of Changcheng Securities in the shareholder registry; 3) the defendant to bear the costs of the case [3][4]. - The court has emphasized that due to the company's revoked status, it is using public announcement methods to deliver legal documents [3][4]. Group 2: Company Background - Shenzhen Sanjiu Weitai was established in 1993 and is a manufacturer of chemical pharmaceutical raw materials [2][6]. - Prior to its revocation, Shenzhen Sanjiu Weitai had four shareholders, including Shenzhen Jiusheng Biological Products Factory (now revoked), Huaxia Securities Co., Ltd., Shenzhen Sanjiu Pharmaceutical Co., Ltd., and other social legal entities [6][8]. Group 3: Historical Context - The company was previously controlled by Sanjiu Enterprise Group, which underwent debt restructuring in the early 2000s, leading to significant changes in ownership and structure [8][9]. - After the restructuring, Sanjiu Enterprise Group was merged into China Resources and became a wholly-owned subsidiary, while its listed company was renamed to "China Resources Sanjiu" [8][9].